08 Mar 2022 --- A study has found lactoferrin, a glycoprotein, has inhibitory potential against select SARS-CoV-2 variants during in vitro settings. In the experiment, bovine lactoferrin supplied by Glanbia Nutritionals inhibited SARS-CoV-2 variant infection by blocking the virus’ ability to enter cells. The glycoprotein was also found to support cells’ antiviral defenses.
